U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

Mitchell Daily Republic

Mar 23, 2021

The vaccine, developed with Oxford University, was 79% effective in preventing symptomatic illness in the large trial that also took place in Chile and Peru, according to the data.